Renato Sergio Marchevsky

Dr. Renato Sergio Marchevsky


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in Virology
Verified
Journal Article
Closed access
PDF file
RGR. Galler
R. Galler
KPK.V. Pugachev
K.V. Pugachev
CSC.L.S. Santos
C.L.S. Santos
SOS.W. Ocran
S.W. Ocran
AJA.V. Jabor
A.V. Jabor
TMT.P. Monath
T.P. Monath

1 April 2011 in Veterinary Microbiology
Verified
Journal Article
Closed access
DSDebora Regina Lopes dos Santos
Debora Regina Lopes dos Santos
VPVanessa de Paula
Vanessa de Paula
JOJaqueline Mendes de Oliveira
Jaqueline Mendes de Oliveira
RMRenato Sergio Marchevsky
Renato Sergio Marchevsky
MPMarcelo Alves Pinto
Marcelo Alves Pinto

1 December 2009 in The Veterinary Journal
Verified
Journal Article
Closed access
DSDebora Regina Lopes dos Santos
Debora Regina Lopes dos Santos
CVClaudia Lamarca Vitral
Claudia Lamarca Vitral
VPVanessa de Paula
Vanessa de Paula
RMRenato Sergio Marchevsky
Renato Sergio Marchevsky
JLJuliana Freitas Lopes
Juliana Freitas Lopes
MPMarcelo Alves Pinto
Marcelo Alves Pinto

1 January 1998 in Experimental and Toxicologic Pathology
Verified
Journal Article
Closed access
MPM.M. Pereira
M.M. Pereira
JAJ. Andrade
J. Andrade
RMRenato Sergio Marchevsky
Renato Sergio Marchevsky
RSR. Ribeiro dos Santos
R. Ribeiro dos Santos

1 January 2005 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MPMartha Pereira
Martha Pereira
JSJoão José Pereira DA Silva
João José Pereira DA Silva
MPMarcelo Alves Pinto
Marcelo Alves Pinto
MSMauro França DA Silva
Mauro França DA Silva
MMMarcelo Pelajo Machado
Marcelo Pelajo Machado
RMRenato Sergio Marchevsky
Renato Sergio Marchevsky
Experimental infection of marmoset monkeys (Callithrix jacchus) with Leptospira interrogans serovar Copenhageni showed microscopic patterns of tissue reactions comparable to those seen in the severe forms of human leptospirosis, including intra-alveolar hemorrhage. The most impressive microscopic changes were seen in the lung and kidney of animals killed at days 6 and 12 after inoculation. There were extensive and irregular areas of hemorrhage predominating around main bronchial branches or diffusely spread to the pulmonary parenchyma, as well as severe tubulointerstitial nephritis. Antibody response detected by the microscopic agglutination test was quantitatively similar to those seen in humans and paralleled severity of tissue lesions. The distribution of leptospires or antigenic debris in infected tissues was observed by immunofluorescence and confocal laser scanning microscopy. Large numbers of typical leptospires were seen in the lumen of proximal renal tubules. Positive reactions showing antigenic debris were closely associated with sites of tissue damage.

22 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NGNoemi Gardinali
Noemi Gardinali
JGJuliana Rodrigues Guimarães
Juliana Rodrigues Guimarães
JMJuliana Gil Melgaço
Juliana Gil Melgaço
YKYohan Britto Kevorkian
Yohan Britto Kevorkian
FBFernanda De Oliveira Bottino
Fernanda De Oliveira Bottino
MPMarcelo Alves Pinto
Marcelo Alves Pinto
Epidemiological studies found that hepatitis E virus genotype 3 (HEV-3) infection was associated with chronic hepatitis and cirrhosis in immunocompromised patients. Our study aimed to investigate the relationship between the host immunosuppressive status and the occurrence of HEV-related chronic hepatitis. Here we describe a successful experimental study, using cynomolgus monkeys previously treated with tacrolimus, a potent calcineurin inhibitor immunosuppressant, and infected with a Brazilian HEV-3 strain isolated from naturally infected pigs. HEV infected monkeys were followed up during 160 days post infection (dpi) by clinical signs; virological, biochemical and haematological parameters; and liver histopathology. The tacrolimus blood levels were monitored throughout the experiment. Immunosuppression was confirmed by clinical and laboratorial findings, such as: moderate weight loss, alopecia, and herpes virus opportunistic infection. In this study, chronic HEV infection was characterized by the mild increase of liver enzymes serum levels; persistent RNA viremia and viral faecal shedding; and liver histopathology. Three out of four immunosuppressed monkeys showed recurrent HEV RNA detection in liver samples, evident hepatocellular ballooning degeneration, mild to severe macro and microvesicular steatosis (zone 1), scattered hepatocellular apoptosis, and lobular focal inflammation. At 69 dpi, liver biopsies of all infected monkeys revealed evident ballooning degeneration (zone 3), discrete hepatocellular apoptosis, and at most mild portal and intra-acinar focal inflammation. At 160 dpi, the three chronically HEV infected monkeys showed microscopic features (piecemeal necrosis) corresponding to chronic hepatitis in absence of fibrosis and cirrhosis in liver parenchyma. Within 4-months follow up, the tacrolimus-immunosuppressed cynomolgus monkeys infected with a Brazilian swine HEV-3 strain exhibited more severe hepatic lesions progressing to chronic hepatitis without liver fibrosis, similarly as shown in tacrolimus-immunosuppressed solid organ transplant (SOT) recipients. The cause-effect relationship between HEV infection and tacrolimus treatment was confirmed in this experiment.